Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program

2026-06-08 – Press Releases – www.prnewswire.com

SAN DIEGO, June 8, 2026 /PRNewswire/ — Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global Clinical Trials (GCT) as the lead contract research organization supporting international…

Read the full article here.